Valuation question - capitalizing r&d
Question for the valuation junkies out there:
I'm valuing a biotech firm and would like to capitalize r&d expenses.
How should this affect the DCF valuation?
I'm assuming that, in any given year (in the forecast period), I should:
-Add back R&D expense to EBIT -Subtract R&D amortization from EBIT -Assume taxes aren't affected -R&D expense at t0 is subtracted from free cash flows (same treatment as CAPEX)
Am I forgetting anything?
if you are running everything on a cash basis, why would you double count the R&D Amort and the capex?
come on now...
well atleast add back the amort when you calculate FCF, I assumed you were just subtracting it.
accounting wise i am not sure you can capitalize these cost, unless this is purely R&D shop, that plans to sell this product once its completed,
GAAP - can't capitalise R&D unless software, biotech etc..
IFRS - can't capitalise R but can D
Dolorem aut dolore quidem nemo voluptas. Esse inventore neque maxime. Vero cupiditate doloribus quod temporibus. Quia officia ut laudantium voluptates molestiae est. Assumenda incidunt rerum repudiandae eaque exercitationem quo. Sunt quae pariatur nobis aliquid excepturi debitis commodi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...